Antibodies: Sequence, Structure and Designing Therapeutics

A two day course that will give you an understanding of antibody research. From bioinformatics to human drug trials including the legal challenges involved.

video: researching and designing antibody therapeutics in Prof Chester lab

UCL, Bloomsbury Campus London

Date: 10th & 11th June 2024

To apply for a place on this course, please send your CV to: biosciences.cpd@ucl.ac.uk

Course leaders

Professor Andrew Martin, Division of Biosciences UCL
Professor Kerry Chester, UCL Cancer Institute

It is estimated that antibodies now represent around one third of all drugs in development. This course consists of lectures and workshops that will teach you how to search for antibodies using powerful bioinformatic software, how to interpret the findings, and how the results are used by Professor Chester to design therapeutics at the UCL Cancer Institute and their use in human drug trials.
Suitable for all scientific disciplines

approved by RSB for 48 credit points

Testimonials

I enjoyed learning about CDR naming, humanization strategies, and the background of how antibodies are named. I also enjoyed learning about AbYsis and its functionalities, as it contains many tools I wasn't aware of.

All the talks gave very good coverage for the major points within the antibodies field leaving the audience at a good point to move on. . . The talks covered the most important aspects of the field including the bioinformatic tools which can be easily applied to the research.

I really enjoyed the two days at UCL. The lunch provision, evening drinks and buffet was lovely. It was great to get acquainted with the lecturers beforehand - this made Q&A a lot more relaxed and informative. Further to this, the memory stick with lecture slides, notebook, pen and printed schedule was a brilliant bonus.“

I really liked meeting the academics and other participants and learning their views.

It covered well all aspects relating to structure, design and intellectual property.

The opportunity to discuss and question afterwards was very useful

I did learn a LOT about antibodies overall. I feel like I now have a good understanding of what the major challenges of antibody engineering are, and related bioinformatics tools and solutions.

Excellent workshop and I would highly recommend it to others.“